Skip to main contentSkip to navigation
Print subscriptions
Newsletters
Sign in

Cancer

  • GSK offices in London

    GSK makes biggest ever acquisition with $10.6bn for US cancer drug firm

    Nuvalent’s late-stage lung cancer treatments zidesamtinib and neladalkib are expected to launch later this year
  • A scientist in a white lab coat looks through a microscope while viewing cell images on a monitor

    First Edition newsletter
    Monday briefing: Are we any closer to a cure for cancer?

    In today’s newsletter: ​Researchers are giving us new insights into early detection and treatments, but with access to life-saving care remaining uneven patients still have a long road ahead
    Newsletter
  • Dr Richard Scolyer, the eminent pathologist and melanoma expert, was diagnosed with grade-four inoperable brain cancer.

    Richard Scolyer, cancer researcher and former Australian of the year, dies aged 59

  • Dr Richard Scolyer

    Richard Scolyer shares his ‘greatest lesson’ in open letter to Australians before his death

  • Prof Richard Scolyer looking out of a window at the University of Sydney

    Richard Scolyer, acclaimed melanoma researcher who tried experimental treatment on his own brain cancer – obituary

  • Healthcare worker talking to a patient who is receiving an MRI Scan

    Record number of people waiting for NHS diagnostic tests in England

  • The Guardian view on cancer treatments: new hope for patients now and in the future

  • NHS hospitals adopt faster, more accurate at-home bladder cancer test

  • Hands holding blister pack of pills

    Removing ‘invisibility cloaks’ and safely skipping chemo: new weapons in war on cancer shared at US conference

    Drug that stops cancer cells hiding and a breakthrough pill for pancreatic cancer among highlights from Asco conference – but there were also notes of caution
  • Polly Toynbee

    double quotation markThe right’s culture war over prostate cancer screening is damaging trust in medicine

    Polly Toynbee
    The decision not to test all men and only screen the most at risk, including black men, is fact-based. Yet it’s been called ‘two tier’ – and labelled as misandry, says Guardian columnist Polly Toynbee
  • operating theatre

    Reassurance for bladder cancer patients

    Letter: Gail Cartmail offers a positive outlook to those facing life-changing bladder surgery, based on her own experience
  • A coloured scanning electron micrograph of ovarian cancer cells

    Life-prolonging drug for advanced ovarian cancer gets go-ahead in England

  • A mobile prostate cancer test van.

    Thousands more UK black men to be invited for prostate cancer screening

  • The artist Tracey Emin.

    Doctors hail drug that spares bladder cancer patients ‘life-changing’ surgery

    Durvalumab shows promising results in trial led by London-based Institute of Cancer Research
  • A woman holding a weight-loss drug injection pen

    Weight-loss drugs can cut breast cancer risk by up to 30%, studies suggest

    Three studies add to evidence that jabs could be part of cancer-fighting toolkit to cut risk of developing or dying from disease
  • Karen sits on her rear patio as Tosh stands with his arm around her shoulder. They are both 59 and have tattoos on their arms. She is quite thin with long, straight blond hair and he is stocky and bald; he wears a red polo top. The patio, decking, fencing, outdoor furniture and white french doors behind them look brand-new.

    ‘They took everything’: arson attack destroyed a mother’s memories of her dead son

    Karen Holmes lost a son to cancer, then her home in Yorkshire to a fire; the house is now refurbished but its meaning has gone
  • Devi Sridhar

    double quotation markCancer is now a story of the good, the bad and the ugly – but also hope

    Devi Sridhar
  • Pat Brogan and his wife Linda

    ‘I was getting ready to say goodbye’: cancer patient’s hope after smart drug success

  • T-cells attack dividing breast cancer cells.

    Smart drug that strips cancer cells of ‘invisibility cloak’ can shrink tumours by 30%, trial shows

  • Ranjana Srivastava

    double quotation markDoctors don’t know what to do about wellness influencers but we dismiss them at our peril

    Ranjana Srivastava
About 5,316 results for Cancer
1234...
Explore more on these topics